Once a drug target is identified, it often takes decades until a chemical compound is developed that can hit the bullseye and ...

PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...

Ultraviolet light causes damage to DNA, leads to cancer and photoaging: age spots and wrinkles. I was curious about this ...

This dual cross-linking design lets the muscle switch stiffness on demand. In lab tests, its stiffness jumps from about 213 ...

PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, and RareSight, Inc., an ...

In this video, we explore the fundamental role of electrons in chemical reactions, rooted in quantum physics and the ...

Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to ...

We've gone to the bottom of the ocean to study how its chemistry shapes our planet's climate, even chasing lava-spewing ...

A computational method accurately predicts the optimal ligand for a photochemical palladium catalyst, enabling new radical reactions of alkyl ketones. Ketones are common components in many organic ...

Chemists envy the ease with which some bacterial enzymes can break carbon–hydrogen bonds. They now imitate the enzyme active site in an oxo-bridged diiron compound that can cleave these strong bonds.